Daniel F. Markgraf

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study

Oana‐Patricia Zaharia, Klaus Straßburger, Alexander Strom et al. · The Lancet Diabetes & Endocrinology · 2019 · 587 citations

Medicine, Endocrinology, Clinical Epidemiology +11

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

S. Kahl, Sofiya Gancheva, Klaus Straßburger et al. · Diabetes Care · 2019 · 343 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The CORVET Tethering Complex Interacts with the Yeast Rab5 Homolog Vps21 and Is Involved in Endo-Lysosomal Biogenesis

Karolina Peplowska, Daniel F. Markgraf, Clemens W. Ostrowicz et al. · Developmental Cell · 2007 · 312 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis

Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki et al. · Diabetes Care · 2018 · 286 citations

Life Sciences, Biochemistry, Endocrinology +17

Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial

Yanislava Karusheva, Theresa Koessler, Klaus Straßburger et al. · American Journal of Clinical Nutrition · 2019 · 175 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17